← All diseases
Brain and nervous system
Multiple sclerosis (progressive)
Do you want to receive a message when there is new research on Multiple Sclerosis (Progressive)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you see one sentence explaining what was investigated — and you'll be notified as soon as new research on Multiple sclerosis (progressive) is published. View what Premium costs.
Publications and studies (1542)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) (2026-01-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis (2026-01-05) ♡
- EBV Early Lytic Antigens, EBNA2 and PDL-1, in Progressive Multiple Sclerosis Brain: A Coordinated Contribution to Viral Immune Evasion. (2025/12/31) ♡
- Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosis. (2025/12/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CAR T cells as novel therapeutic strategy for multiple sclerosis and other neuroimmune disorders. (2025/12/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Comparative Efficacy of Autologous Hematopoietic and Mesenchymal Stem Cell Transplantation in Patients with Systemic Sclerosis: A Systematic Review. (2025/12/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From lesion detection to outcome prediction: artificial intelligence and deep learning applications in multiple sclerosis. (2025/12/27) ♡
- The Effect of Progressive Muscle Relaxation Exercise on Symptoms and General Well-being of Patients With Multiple Sclerosis: Systematic Review and Meta-analysis. (2025/12/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cell Therapy in Multiple Sclerosis: Clinical Advances, Limitations, and Future Perspectives from Clinical Studies-A Systematic Review. (2025/12/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Shaping the role of plasma exchange in autoimmune neurology: lessons learned from 67 years and over 90,000 procedures. (2025/12/24) ♡
- Temporal Dynamics of Pulmonary Fibrosis and Immune Dysregulation in a Collagen V-Driven Systemic Sclerosis Model. (2025/12/24) ♡
- Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial. (2025/12/23) ♡
- Epidemiological characteristics of treated multiple sclerosis patients - Lublin experience (South-Eastern Poland). (2025/12/22) ♡
- Anti-BCMA CAR-T cells attenuate microglial activation in progressive multiple sclerosis: indicating a plasma cell-microglia crosstalk. (2025/12/20) ♡
- Factors associated with the progression of disability (EDSS) among MS patients. (2025/12/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunopathogenic Mechanisms in Connective Tissue Disease-Associated Interstitial Lung Disease: Incessant Loop of Immunity to Fibrosis. (2025/12/17) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Assessment of Functional Status in Patients with Multiple Sclerosis Based on the Inflammatory Potential of Their Diet. (2025/12/17) ♡
- Retinal nerve fiber layer thinning in multiple sclerosis: clinical implications, cognitive associations, and effects of disease-modifying therapies. (2025/12/14) ♡
- Pharmacological Activation of Mitophagy Confers Neuroprotective Benefits for Amyotrophic Lateral Sclerosis. (2025/12/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple Sclerosis Agents. (2025/12/12) ♡
- Sex differences in progressive multiple sclerosis brain gene expression in oligodendrocytes and OPCs. (2025/12/12) ♡
- Real-World Data on Switches of the Employment Status in People with Multiple Sclerosis: A Longitudinal Observational Study of the German MS Register. (2025/12/11) ♡
- Rare variation in neurological disease genes and its role in multiple sclerosis mimicry and phenotype. (2025/12/10) ♡
- Clinical, functional and cognitive features of late-onset multiple sclerosis. (2025/12/08) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy. (2025/12/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fetal cardiac rhabdomyomas susceptible to prenatal treatment with mTOR inhibitors: literature review and proposal of a prenatal management algorithm. (2025/12/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute Spinal Cord Syndrome As the Initial Manifestation of Multiple Sclerosis: A Case Report. (2025/12/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Combined intrathecal and intravenous exosome injection efficiency in a multiple sclerosis patient: a case report. (2025/12/06) ♡
- From diagnosis to treatment: patterns in disease-modifying therapy initiation in multiple sclerosis. (2025/12/05) ♡
- Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types. (2025/12/04) ♡
- Novel missense ALDH18A1 variant in a family with autosomal dominant spastic paraplegia. (2025/12/04) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Risks and Benefits of Gastrostomy in Non-Motor Neurone Disease Progressive Neurological Diseases: A Systematic Review. (2025/12/01) ♡
- Geriatric syndromes in intestinal failure: An accelerated aging phenomenon in middle adulthood patients? (2025/12/01) ♡
- Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis. (2025/12/01) ♡
- Effect of Ibudilast vs Placebo on GFAP and Contactin levels in a phase 2 clinical trial in progressive multiple sclerosis. (2025/12/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Motor imagery training promotes motor learning and brain plasticity without fatigability in people with progressive multiple sclerosis. (2025/12/01) ♡
- Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database. (2025/12/01) ♡
- Predicting Quality of Life in Relapsing-Remitting Multiple Sclerosis: Clinical Burden Meets Emotional Balance in Early Disease. (2025/12/01) ♡
- From youth to late age: a comparative analysis of clinical and demographic profiles in multiple sclerosis by age at onset. (2025/12/01) ♡
- Unraveling cholesterol metabolism in multiple sclerosis: Gender-specific patterns and predictive biomarkers. (2025/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic exercise in multiple sclerosis: Mechanisms of neuroprotection, modality-specific benefits, and technology-enhanced delivery frameworks. (2025/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis. (2025/11/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Treatment-resistant Inflammatory Demyelinating Pseudotumor with Marburg-Like Features: A Rare Case Report. (2025/11/28) ♡
- In vivo characterization of a retinal cellular biomarker of inflammation in multiple sclerosis. (2025/11/28) ♡
- SYNE1 Deficiency Manifesting Primarily With Motor Neuron Disease. (2025/11/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Adult Onset of Type 2 Familial Hemophagocytic Lymphohistiocytosis After SARS-CoV-2 Vaccination with an Unusual Neurological Onset: The Great Mimic. (2025/11/26) ♡
- Optimization of cervical cord atrophy measurement using a real-world, multicentre dataset in multiple sclerosis. (2025/11/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Challenging Uncommon Presentation of Steroid-Resistant Tumefactive Multiple Sclerosis: A Brainstem Crisis Resolved With Plasma Exchange and Ocrelizumab Maintenance. (2025/11/26) ♡
- Assessing Peripheral Blood Biomarkers and Predictive Patterns in Multiple Sclerosis Using Cytokines and Immune Gene Expression Profiles in Ocrelizumab-Treated Patients: Tracking Tumor Necrosis Factor. (2025/11/22) ♡
- Cladribine Preserves Normal Central Nervous System Cellular Activity and Promotes Neuroprotection to Oxidative Stress Damage. (2025/11/22) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.